April 03, 2014
In Re: Aggrenox Antitrust Litigation
Case Number:
3:14-md-02516
Court:
Nature of Suit:
Multi Party Litigation:
Class Action, Multi-district Litigation
Judge:
Firms
- King & Spalding
- Hurwitz Sagarin
- Reinhardt Wendorf
- Stevens & Lee
- Ahern & Associates
- Quinn Connor Weaver
- Ballard Spahr
- Capozzi Adler
- Norton Rose
- Levin Sedran
- Carmody Torrance Sandak & Hennessey LLP
- Paul Hastings
- Hilliard & Shadowen
- Smith Segura Raphael & Leger
- Girard Sharp
- Jones Day
- Nixon Peabody
- Garwin Gerstein
- Lockridge Grindal
- Zayas Law Firm
- Cohen Placitella
- Roche Pia LLC
- Barrett Johnston
- Odom & Des Roches
- DiCello Levitt
- Spector Roseman
- Heins Mills
- Hayber McKenna
- Pomerantz LLP
- Faruqi & Faruqi
- Heim Payne
- Hagens Berman
- Wiley Rein
- Motley Rice
- Blank Rome
- Goodwin Procter
- Cowdery Murphy
- Nussbaum Law Group
- Baker & Miller
- Brenner Saltzman
- Stoll Berne
- Scott&Scott
- Hausfeld LLP
- Hangley Aronchick
- Gibson Dunn
- Pullman & Comley
- Day Pitney
- Lowey Dannenberg
- Taus Cebulash
- Milberg Coleman
- Simmons Hanly
- Cohen Milstein
- Sperling Kenny
- Zimmerman Reed
- Berger Montague
- Glancy Prongay
- Connolly Wells
- Baker Donelson
- Winstead PC
- Shipman & Goodwin
- Bass Berry
- Lauletta Birnbaum
- Grant & Eisenhofer
- Labaton Keller
- Latham & Watkins
- White & Case
Companies
- CVS Health Corp.
- Association for Accessible Medicines
- The Kroger Co.
- Gyma Laboratories of America Inc.
- Bi-Lo
- Humana Inc.
- The Cigna Group
- Safeway Inc.
- Rochester Drug Cooperative Inc.
- Boehringer Ingelheim Vetmedica Inc.
- International Union of Painters & Allied Trades
- Florida Blue
- Aetna Inc.
- Boehringer Ingelheim Corp.
- Pirelli & Co.
- BlueCross BlueShield of Tennessee Inc.
- Rite Aid Corp.
- Winn-Dixie Stores, Inc.
- H‑E‑B LP
- Teva Pharmaceutical Industries Ltd.
Sectors & Industries:
View recent docket activity
Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.
Coverage
-
October 29, 2019
Allergan's $750M Deal Among Pharma's Top Antitrust Payouts
A $750 million settlement this week by Allergan to avert an antitrust trial involving Alzheimer's drug Namenda is among the most eye-popping sums ever shelled out by a drugmaker for allegedly thwarting generic competition.
Parties
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Direct access to case information and documents.
- All significant new filings across U.S. federal district courts, updated hourly on business days.
- Full-text searches on all patent complaints in federal courts.
- No-fee downloads of the complaints and so much more!
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login